Curida AS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Curida AS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11030
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥100,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Curida AS (Curida) is a contract development and manufacturing organization that manufactures sterile liquid pharmaceuticals based on unit-dose Blow-Fill-Seal (BFS) technology. It specializes in the development of nasal and inhalation drug products. The company provides laboratory, analytical, chemical testing, stability studies and microbiological services among others. Curida’s method development and validation services include identification, assay testing, testing for impurities, stability indication methods and microbiological method development. The company caters its products and services to start-ups and early stage biotechnology and pharmaceutical companies. It operates through its manufacturing facility located in Elverum, Norway. Curida is headquartered in Oslo, Norway.

Curida AS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Curida AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curida AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curida AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curida AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Curida AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Curida AS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Curida Raises USD3 Million in Venture Financing 10
Curida Raises USD5.9 Million in Venture Financing 11
Acquisition 12
Curida Acquires As Produksjonslab from Serviceproduksjon 12
Curida AS – Key Competitors 13
Curida AS – Key Employees 14
Curida AS – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Other Significant Developments 16
Jan 23, 2018: Governmental Fund Investinor Invests In Curida 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Curida AS, Pharmaceuticals & Healthcare, Key Facts 2
Curida AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curida AS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Curida AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curida AS, Deals By Therapy Area, 2012 to YTD 2018 8
Curida AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Curida Raises USD3 Million in Venture Financing 10
Curida Raises USD5.9 Million in Venture Financing 11
Curida Acquires As Produksjonslab from Serviceproduksjon 12
Curida AS, Key Competitors 13
Curida AS, Key Employees 14
Curida AS, Other Locations 15

List of Figures
Curida AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Curida AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Curida AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Curida AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Curida AS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Curida AS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Curida AS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Curida AS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Curida AS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Xtreme Drilling Corp (XDC):石油・ガス:M&Aディール及び事業提携情報
    Summary Xtreme Drilling Corp (Xtreme Drilling), formerly Xtreme Drilling and Coil Services Corp is an onshore drilling rig service provider for oil and gas service companies. The company's products include coiled tubing units, drilling rigs, variable frequency drive systems, integrated AC top drives …
  • Icon Energy Ltd (ICN):企業の財務・戦略的SWOT分析
    Summary Icon Energy Ltd (Icon Energy), formerly Icon Oil NL, is an oil and gas exploration and production company that acquires, explores, and develops oil and gas properties. The company's exploration tenements include ATP 855, PRL's 33-49, ATP 594, ATP 626, ATP 794, ATP 549 West, PEP 170, PEP 172, …
  • Harvard Bioscience Inc (HBIO):医療機器:M&Aディール及び事業提携情報
    Summary Harvard Bioscience Inc (Harvard Bioscience) develops, manufactures and markets scientific instruments systems and lab consumables. The company’s product portfolio encompasses physiology, cell, molecular instruments products; electrophysiology products; and laboratory products and supplies. I …
  • Old Dominion Freight Line, Inc. (ODFL):企業の財務・戦略的SWOT分析
    Old Dominion Freight Line, Inc. (ODFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Intercept Pharmaceuticals Inc (ICPT)-製薬・医療分野:企業M&A・提携分析
    Summary Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for non-viral, progressive liver diseases. It develops products using its proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid ( …
  • Hexion Inc.:戦略・SWOT・企業財務分析
    Hexion Inc. - Strategy, SWOT and Corporate Finance Report Summary Hexion Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Legg Mason Inc:企業の戦略・SWOT・財務情報
    Legg Mason Inc - Strategy, SWOT and Corporate Finance Report Summary Legg Mason Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Genmab AS (GEN):企業の財務・戦略的SWOT分析
    Genmab AS (GEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • NBCUniversal Media LLC:企業の戦略・SWOT・財務情報
    NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report Summary NBCUniversal Media LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ballard Power Systems Inc. (BLDP)-エネルギー分野:企業M&A・提携分析
    Summary Ballard Power Systems Inc. (Ballard Power) is a renewable energy company. It designs, develops, manufactures, sells, and services proton exchange membrane (PEM) fuel cell products for power product markets, portable power, and material handling and backup power. The company’s product lines i …
  • Affibody AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Affibody AB (Affibody) is a biotech company that discovers and develops next generation biopharmaceuticals and related drugs. The company discovers and develops drugs based on its proprietary technology platforms such as Albumod and Affibody molecules. Its Affibody molecules are a class of a …
  • Cyprotex Ltd-医療機器分野:企業M&A・提携分析
    Summary Cyprotex Ltd (Cyprotex), a subsidiary of Evotec AG is a provider of ADME-Tox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company’s core capabilities include high quality mechanistic toxicolo …
  • First Pacific Company Limited:企業の戦略・SWOT・財務分析
    First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report Summary First Pacific Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Advanced Medical Electronics Corp:製品パイプライン分析
    Summary Advanced Medical Electronics Corp (AME) is a medical device company that offers research and development services. The company provides electrocardiograph and spirometer equipment. It provides battery powered surgical headlamp, oximeter, partial polysomnograph, and computerized visual acuity …
  • Philip Morris International Inc.:企業の戦略・SWOT・財務情報
    Philip Morris International Inc. - Strategy, SWOT and Corporate Finance Report Summary Philip Morris International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • VP Bank AG (VPBN):企業の財務・戦略的SWOT分析
    Summary VP Bank AG (VP Bank) is a financial service provider that offers banking services, asset management, and portfolio advisory services to institutional and private investors. The company provides a wide variety of house solutions, third-party financial products through a network of strategical …
  • National Electric Power Co:企業の戦略的SWOT分析
    National Electric Power Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Calfrac Well Services Ltd (CFW):企業の財務・戦略的SWOT分析
    Calfrac Well Services Ltd (CFW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Santhera Pharmaceuticals Holding AG (SANN):製薬・医療:M&Aディール及び事業提携情報
    Summary Santhera Pharmaceuticals Holding AG (Santhera) develops and commercializes novel pharmaceutical products indicated for patients with mitochondrial and neuromuscular diseases. It specifically focuses in the area of neuromuscular and neuro-ophthalmological conditions. The company’s lead produc …
  • Asklepios BioPharmaceutical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Asklepios Biopharmaceutical Inc (AskBio) is a biotechnology company that develops and markets novel protein and cellular based therapies. The company has developed library of rAAV biological nano particles that provides unsurpassed transduction. Its products include such as biostrophin, AskB …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆